您要查找的是不是：
- Neoadjuvant chemothempy 新辅助化疗
- OBJECTIVE: To evaluate the status quo of the application of neoadjuvant chemotherapy. 目的:对新辅助化疗方案的临床应用现状进行评价。
- Retrospective Study of Neoadjuvant Chemotherapy in Operable Oral Cavity Cancer Patients. 口腔鳞癌新辅助化疗的回顾性研究。
- The effective rate(CR+PR)for neoadjuvant chemotherapy was 61.8%(34/55),complete remission rate(CR)was 9.1%(5/55). 术前化疗有效率(CR+PR)为61.;8%25(34/55);完全缓解率(CR)为9
- In this article, we review our long-term experience of neoadjuvant chemotherapy of advanced stage (III-IVA) thymomas. 在本文中，我们回顾了晚期(III-IVA)胸腺瘤进行新辅助化疗这个长期的过程。
- This article reviewed the development and current status of neoadjuvant therapy for rectal cancer. 本文详细论述了直肠癌新辅助治疗的发展和现状。
- Objective:To evaluate the effect of neoadjuvant therapy in the treatment of lo-cally advanced breast cancer. 探讨新辅助治疗在局部晚期乳腺癌治疗中的应用。
- This review presents the present state and future prospect of neoadjuvant chemotherapy for advanced breast cancer. 现就新辅助化疗在乳腺癌治疗中的现状及展望作一综述。
- Objective: To evaluate the effect of neoadjuvant arterial chemoemblization on locally advanced cervical carcinoma. 摘要目的：评价新辅助动脉栓塞化疗在局部晚期宫颈癌患者治疗中的作用。
- The neoadjuvant chemotherapy is a hot spot in the combined therapy for rectal cancer in recent years. 近年来,新辅助化疗已成为直肠癌综合治疗中的一个热点。
- We compared neoadjuvant radiation,neoadjuvant chemoradiation with surgery alone and adjuvant therapy. 探讨了新辅助放疗、新辅助放化疗与单纯手术及辅助化放疗相比的优劣。
- The present status of neoadjuvant chemotherapy for the treatment of gastric cancer was reviewed in this article. 该文主要对近年来新辅助化疗在胃癌治疗中的现状进行了综述。
- Neoadjuvant chemotherapy (NACT) has benefitted many and many patients with primary breast cancer. 新辅助化疗已经使众多原发性乳腺癌患者受益。
- Objective To observe the effects of FOLFOX4 neoadjuvant chemotherapy protocol on advanced gastric cancer. 目的 观察FOLFOX4新辅助化疗方案在进展期胃癌综合治疗中的作用。
- The overall response rate of neoadjuvant chemotherapy was 69.66%. The response rate of CMF regimen was 50.00%; anthracycline regimen, 73.97%. [结果]新辅助化疗总的有效率为69.;66%25;其中CMF方案有效率为50
- Objectives: To investigate the feasibility of neoadjuvant chemotherapy (NAC) applied on patients with unresectable epithelial ovarian cancer (EOC). 目的:探讨对于首次手术难以达到满意肿瘤细胞减灭术的上皮性卵巢癌患者,采用新辅助化疗(neoadjuvant chemotherapy,NAC)治疗的可行性。
- Neoadjuvant chemotherapy can minish burthen of tumor and lower the clinical stage,and increase resection rate of cancer. 新辅助化疗可以减小肿瘤负荷,降低临床病期,提高肿瘤的手术切除率。
- In the trial, 104 patients in the neoadjuvant subset received chemotherapy, and 101 patients received chemotherapy plus zoledronic acid. 试验中，104名患者接受了新的化疗疗法，101名患者接受化疗辅助于唑来膦酸治疗。
- Objective To observe the efficacy and adverse effects of neoadjuvant chemotherapy with THP or ADM in patients with breast cancer. 目的对比观察采用吡柔比星(THP)和多柔比星(ADM)为主的新辅助化疗方案治疗乳腺癌的疗效和毒副作用。
- CONCLUSION: Neoadjuvant chemotherapy plus combined radical surgery can resect the primary tumors and metastatic lymph nodes maximally. 可以最大限度地切除肿瘤及转移淋巴结。
